Clinical benefit from resection of recurrent glioblastomas: Results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Florian Ringel - , Technische Universität München (Autor:in)
  • Haiko Pape - , Technische Universität München (Autor:in)
  • Michael Sabel - , Heinrich Heine Universität Düsseldorf (Autor:in)
  • Dietmar Krex - , Klinik und Poliklinik für Neurochirurgie, Technische Universität Dresden (Autor:in)
  • Hans Christoph Bock - , Georg-August-Universität Göttingen (Autor:in)
  • Martin Misch - , Charité – Universitätsmedizin Berlin (Autor:in)
  • Astrid Weyerbrock - , Albert-Ludwigs-Universität Freiburg (Autor:in)
  • Thomas Westermaier - , Julius-Maximilians-Universität Würzburg (Autor:in)
  • Christian Senft - , Universitätsklinikum Frankfurt (Autor:in)
  • Philippe Schucht - , Universität Bern (Autor:in)
  • Bernhard Meyer - , Technische Universität München (Autor:in)
  • Matthias Simon - , Universität Bonn (Autor:in)

Abstract

Background While standards for the treatment of newly diagnosed glioblastomas exist, therapeutic regimens for tumor recurrence remain mostly individualized. The role of a surgical resection of recurrent glioblastomas remains largely unclear at present. This study aimed to assess the effect of repeated resection of recurrent glioblastomas on patient survival. Methods In a multicenter retrospective-design study, patients with primary glioblastomas undergoing repeat resections for recurrent tumors were evaluated for factors affecting survival. Age, Karnofsky performance status (KPS), extent of resection (EOR), tumor location, and complications were assessed. Results Five hundred and three patients (initially diagnosed between 2006 and 2010) undergoing resections for recurrent glioblastoma at 20 institutions were included in the study. The patients' median overall survival after initial diagnosis was 25.0 months and 11.9 months after first re-resection. The following parameters were found to influence survival significantly after first re-resection: preoperative and postoperative KPS, EOR of first re-resection, and chemotherapy after first re-resection. The rate of permanent new deficits after first re-resection was 8%. Conclusion The present study supports the view that surgical resections of recurrent glioblastomas may help to prolong patient survival at an acceptable complication rate.

Details

OriginalspracheEnglisch
Seiten (von - bis)96-104
Seitenumfang9
FachzeitschriftNeuro-oncology
Jahrgang18
Ausgabenummer1
PublikationsstatusVeröffentlicht - 1 Jan. 2016
Peer-Review-StatusJa

Externe IDs

PubMed 26243790

Schlagworte

Ziele für nachhaltige Entwicklung

Schlagwörter

  • glioblastoma, overall survival, recurrent tumor, surgical resection